Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

AMPK activation may reduce melanoma risk in red-haired individuals.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

The formulated gel is a promising treatment for alopecia areata.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Further research is needed to develop effective cancer prevention strategies.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Baricitinib works better than methotrexate for severe alopecia areata.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Baricitinib is the most effective treatment for alopecia areata.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.